Detecting and genotyping high-risk human papillomavirus among male patients during 2015–2023 in Beijing, China

References

• Xu M-Y, Cao B, Chen Y, et al. Prevalence and type distribution of human papillomavirus in a Chinese urban population between 2014 and 2018: a retrospective study. PeerJ. 2020;8:e8709. doi:10.7717/peerj.8709
   PubMed Web of Science ®Google Scholar
• Zhu C, Wang Y, Mao W, et al. Prevalence and distribution of HPV types in genital warts in Xi’an, China: a prospective study. BMJ Open. 2019;9:e023897. doi:10.1136/bmjopen-2018-023897
   PubMed Web of Science ®Google Scholar
• de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664–670. doi:10.1002/ijc.30716
   PubMed Web of Science ®Google Scholar
• Chen X, Li L, Lai Y, et al. Characteristics of human papillomaviruses infection in men with genital warts in Shanghai. Oncotarget. 2016;7:53903–53910. doi:10.18632/oncotarget.9708
   PubMedGoogle Scholar
• Feng D, Wei S, Chen J, et al. Human papillomavirus prevalence and genotype distribution landscapes in Shannan City, Tibet Tibetan autonomous region, China. Virol J. 2022;19:46. doi:10.1186/s12985-022-01775-5
   PubMed Web of Science ®Google Scholar
• Yang X, Li Y, Tang Y, et al. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infect. 2023;12:e2176009. doi:10.1080/22221751.2023.2176009
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Li K, Li Q, Song L, et al. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125:1030–1037. doi:10.1002/cncr.32003
   PubMed Web of Science ®Google Scholar
• Yuanyue L, Baloch Z, Yasmeen N, et al. The distribution of human papillomavirus genotypes in cervical cancer and intraepithelial neoplasia lesions among Chinese women in Yunnan Province. J Infect Public Health. 2018;11:105–110. doi:10.1016/j.jiph.2017.06.012
   PubMed Web of Science ®Google Scholar
• Yin W-G, Yang M, Peng L, et al. Male papillomavirus infection and genotyping in the Qingyuan area. Virol J. 2020;17:155. doi:10.1186/s12985-020-01423-w
   PubMed Web of Science ®Google Scholar
• Wei F, Yin K, Wu X, et al. Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study. Emerg Microbes Infect. 2016;5:1–8. doi:10.1038/emi.2016.118
   PubMed Web of Science ®Google Scholar
• Ventimiglia E, Horenblas S, Muneer A, et al. Human papillomavirus infection and vaccination in males. Eur Urol Focus. 2016;2:355–362. doi:10.1016/j.euf.2016.08.012
   PubMedGoogle Scholar
• Xu Y, Zhang Y, Fan X, et al. Prevalence and genotypes of human papillomavirus among men in yunnan province, China. Jpn J Infect Dis. 2021;74:280–284. doi:10.7883/yoken.JJID.2020.749
   PubMed Web of Science ®Google Scholar
• Li X, Xiang F, Chen Z, et al. Genital human papillomavirus prevalence and genotyping among males in putuo district of Shanghai, China 2015–2019. Med Sci Monit. 2021;27; doi:10.12659/MSM.932093
   Web of Science ®Google Scholar
• Kosen S, Andrijono A, Ocviyanti D, et al. The cost-effectiveness of quadrivalent human papillomavirus vaccination in Indonesia. Asian Pac J Cancer Prev. 2017;18; doi:10.22034/APJCP.2017.18.7.2011
   PubMedGoogle Scholar
• Xin HN, Li HJ, Li Z, et al. Genital HPV infection among heterosexual and homosexual male attendees of sexually transmitted diseases clinic in Beijing, China. Epidemiol Infect. 2017;145:2838–2847. doi:10.1017/S0950268817001698
   PubMed Web of Science ®Google Scholar
• Liu X, Lin H, Chen X, et al. Prevalence and genotypes of anal human papillomavirus infection among HIV-positive vs. HIV-negative men in Taizhou, China. Epidemiol Infect. 2019;147:e117. doi:10.1017/S0950268818003205
   PubMed Web of Science ®Google Scholar
• Quinn R, Salvatierra J, Solari V, et al. Human papillomavirus infection in men who have sex with men in Lima, Peru. AIDS Res Hum Retroviruses. 2012;28:1734–1738. doi:10.1089/aid.2011.0307
   PubMed Web of Science ®Google Scholar
• Pesic A, Krings A, Schreckenberger C, et al. Analytical evaluation of the human papillomavirus HPV DNA array E1-based genotyping assay. Intervirology. 2019;62:124–133. doi:10.1159/000502207
   PubMed Web of Science ®Google Scholar
• Del Río-Ospina L, Soto-De León SC, Camargo M, et al. Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors. Epidemiol Infect. 2017;145:1479–1490. doi:10.1017/S0950268817000188
   PubMed Web of Science ®Google Scholar
• Bzhalava D, Guan P, Franceschi S, et al. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 2013;445:224–231. doi:10.1016/j.virol.2013.07.015
   PubMed Web of Science ®Google Scholar
• Wang R, Guo X, Wisman G, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015;15:257. doi:10.1186/s12879-015-0998-5
   PubMed Web of Science ®Google Scholar
• Crow JM. HPV: The global burden. Nature. 2012;488:S2–S3. doi:10.1038/488S2a
   PubMed Web of Science ®Google Scholar
• Bhatla N, Lal N, Bao Y-P, et al. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine. 2008;26:2811–2817. doi:10.1016/j.vaccine.2008.03.047
   PubMed Web of Science ®Google Scholar
• Bao Y-P, Li N, Smith JS, et al. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2008;18:71–79. doi:10.1111/j.1525-1438.2007.00959.x
   PubMed Web of Science ®Google Scholar
• Kim M-J, Kim JJ, Kim S. Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: data from the health check-ups of 7,014 Korean women. Obstet Gynecol Sci. 2013;56:110–120. doi:10.5468/OGS.2013.56.2.110
   PubMedGoogle Scholar
• Luo G, Sun X, Li M, et al. Cervical human papillomavirus among women in Guangdong, China 2008–2017: implication for screening and vaccination. J Med Virol. 2019;91:1856–1865. doi:10.1002/jmv.25520
   PubMed Web of Science ®Google Scholar
• Zhao F-H, Tiggelaar SM, Hu S-Y, et al. A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol. 2012;36:384–390. doi:10.1016/j.canep.2012.01.009
   PubMed Web of Science ®Google Scholar
• Schlecht NF. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001;286:3106. doi:10.1001/jama.286.24.3106
   PubMed Web of Science ®Google Scholar
• Takahashi S, Shimizu T, Takeyama K, et al. Detection of human papillomavirus DNA on the external genitalia of healthy Men and male patients with urethritis. Sex Transm Dis. 2003;30:629–633. doi:10.1097/01.OLQ.0000085184.68124.B3
   PubMed Web of Science ®Google Scholar
• Pow-Sang MR, Ferreira U, Pow-Sang JM, et al. Epidemiology and natural history of penile cancer. Urology. 2010;76:S2–S6. doi:10.1016/j.urology.2010.03.003
   PubMed Web of Science ®Google Scholar
• Li WJ, Xu HX, Chen ZH, et al. Characteristics of carcinogenic human papillomavirus infection in Suzhou: epidemiology, vaccine evaluation, and associated diseases. J Med Virol. 2017;89:895–901. doi:10.1002/jmv.24700
   PubMed Web of Science ®Google Scholar
• Xiao J, Ren L, Lv H, et al. Atypical microorganisms in expressed prostatic secretion from patients with chronic prostatitis/chronic pelvic pain syndrome: microbiological results from a case-control study. Urol Int. 2013;91:410–416. doi:10.1159/000350934
   PubMed Web of Science ®Google Scholar
• Vela S, Videla S, Ornelas A, et al. Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men. PLoS One. 2018;13:e0199033. doi:10.1371/journal.pone.0199033
   PubMed Web of Science ®Google Scholar
• Li M, Zhao C, Zhao Y, et al. Immunogenicity, efficacy, and safety of human papillomavirus vaccine: data from China. Front Immunol. 2023;14:1112750. doi:10.3389/fimmu.2023.1112750
   PubMed Web of Science ®Google Scholar
• Chambers C, Deeks SL, Sutradhar R, et al. Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men. J Infect Dis. 2023;228:89–100. doi:10.1093/infdis/jiad005
   PubMed Web of Science ®Google Scholar
• Frazer IH. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology. 2009;384:410–414. doi:10.1016/j.virol.2008.10.004
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram S, You J. Targeting persistent human papillomavirus infection. Viruses. 2017;9:229. doi:10.3390/v9080229
   PubMed Web of Science ®Google Scholar
• Radley D, Saah A, Stanley M. Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease. Hum Vaccines Immunother. 2016;12:768–772. doi:10.1080/21645515.2015.1088616
   PubMed Web of Science ®Google Scholar
• Gillison ML. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–720. doi:10.1093/jnci/92.9.709
   PubMed Web of Science ®Google Scholar
• Hoffman SR, Le T, Lockhart A, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review. Int J Cancer. 2017;141:8–23. doi:10.1002/ijc.30623
   PubMed Web of Science ®Google Scholar
• Bettampadi D, Sirak BA, Abrahamsen ME, et al. Factors associated with persistence and clearance of high-risk oral human papillomavirus (HPV) among participants in the HPV infection in men (HIM) study. Clin Infect Dis. 2021;73:e3227–e3234. doi:10.1093/cid/ciaa1701
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang B, Zhang A, et al. Association between human papillomavirus type 16 E6 and E7 variants with subsequent persistent infection and recurrence of cervical high-grade squamous intraepithelial lesion after conization: HPV type 16 variants and persistent infection. J Med Virol. 2016;88:1982–1988. doi:10.1002/jmv.24541
   PubMed Web of Science ®Google Scholar
• Zheng K, Egawa N, Shiraz A, et al. The reservoir of persistent human papillomavirus infection; strategies for elimination using anti-viral therapies. Viruses. 2022;14:214. doi:10.3390/v14020214
   PubMed Web of Science ®Google Scholar